Great lecture on endocrine therapy for breast cancer by Matteo Lambertini
Matteo Lambertini shared a post by Tatsunori Shimoi, Medical Doctor at National Cancer Center Hospital, on X
“So kind of you! It has been such a pleasure to meet you and to have had the chance to share the same session…looking forward to future collaborations and to visiting you in beautiful Tokyo again!”
Quoting Tatsunori Shimoi’s post:
“Today, Dr. Matteo Lambertini, visiting Japan for the second time, gave a great lecture on endocrine therapy for breast cancer. I asked him about the relationship between BRCA mutations and Rb1 LOH, as well as the efficacy of CDK4/6 inhibitors, and I also asked him about research trends related to young breast cancer. He was a great person and I would have loved to bring him to some good ramen in TOKYO.”
Source: Matteo Lambertini/X and Tatsunori Shimoi/X
Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy. He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis.
Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer. He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023